Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4137381 | Pathophysiology | 2009 | 6 Pages |
Abstract
Glucocorticoid (GC) hormones exert an antiproliferative effect on various cells. The effect is mainly mediated by glucocorticoid receptor (GR) which acts as a transcription factor. Ligand-bound GR translocates from the cytoplasm into the nucleus to modulate gene expression in a variety of ways. Although the framework of transcriptional regulation by the GC/GR has been described, the molecular mechanism of antiproliferative effect of GC is still largely unclear. In this article, we reviewed GC-induced changes in gene expression that are involved in GC-antiproliferative effect, and mainly focused on our recently identified glucocorticoid-responsive genes, TGF-β receptor type II (TβRII) and small GTP binding protein RhoB. We found that expressions of TβRII and RhoB were up-regulated by ligand-bound GR at mRNA and protein levels. Blocking the effect of TβRII by TβRII neutralizing antibody or reduction of RhoB mRNA expression by RNAi diminished dexamethasone-inhibitory effect on cell proliferation, thus confirming that these genes are involved in GC anti-proliferation effect. Collectively, GC up-regulating the expressions of RhoB and TβRII play an important role in GC anti-proliferation effect.
Keywords
Type II TGF-β receptorRhoBTβRITGF-β1DEXGAPDHCKITβRIIRT-PCRGCsGRE3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromideMTTRNA interferenceRNAiTransforming growth factor-β1Cell proliferationDexamethasoneglucocorticoid response elementsCyclin-dependent kinase inhibitorsreverse transcription-polymerase chain reactionGlucocorticoidGlucocorticoidsglyceraldehydes-3-phosphate dehydrogenaseglucocorticoid receptor
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Jian Lu,